Acrylonitrile derivatives for inflammation and immune-related uses

Details for Australian Patent Application No. 2005226741 (hide)

Owner Synta Pharmaceuticals Corp.

Inventors Ying, Weiwen; Ono, Mitsunori; Jiang, Jun; Chen, Shoujun; Sun, Lijun

Agent Griffith Hack

Pub. Number AU-A-2005226741

PCT Pub. Number WO2005/091752

Priority 60/556,107 25.03.04 US

Filing date 24 March 2005

Wipo publication date 6 October 2005

International Classifications

C07D 231/14 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/415 (2006.01) - 1,2-Diazoles

Event Publications

9 November 2006 PCT application entered the National Phase

  PCT publication WO2005/091752 Priority application(s): WO2005/091752

21 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005226743-Three by four can package dispensing carton

2005226736-Use of anti-alpha5beta1 antibodies to inhibit cancer cell proliferation